TY - JOUR
T1 - Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome
T2 - First report of the IAIHG retrospective registry
AU - Slooter, Charlotte D.
AU - Van Den Brand, Floris F.
AU - Lleo, Ana
AU - Colapietro, Francesca
AU - Lenzi, Marco
AU - Muratori, Paolo
AU - Kerkar, Nanda
AU - Dalekos, G.
AU - Zachou, Kalliopi
AU - Lucena, M. Isabel
AU - Robles-Díaz, Mercedes
AU - Di Zeo-Sánchez, Daniel E.
AU - Andrade, Raúl J.
AU - Montano-Loza, Aldo J.
AU - Lytvyak, Ellina
AU - Lissenberg-Witte, Birgit I.
AU - Maisonneuve, Patrick
AU - Bouma, Gerd
AU - MacEdo, Guilherme
AU - Liberal, Rodrigo
AU - De Boer, Ynto S.
AU - Almasio, P.
AU - Alvarez, F.
AU - Andrade, R.
AU - Arikan, C.
AU - Assis, D.
AU - Bardou-Jacquet, E.
AU - Biewenga, M.
AU - Van Hoek, B.
AU - De Boer, Y.
AU - Van Nieuwkerk, C.
AU - Cancado, E.
AU - Cazzagon, N.
AU - Chazouillères, O.
AU - Colloredo, G.
AU - Cuarterolo, M.
AU - Ines Lopez, S.
AU - Dalekos, G.
AU - Gatselis, N.
AU - Debray, D.
AU - Robles-Díaz, M.
AU - Drenth, J.
AU - Dyson, J.
AU - Efe, C.
AU - Engel, B.
AU - Van Erpecum, K.
AU - Baak, L. C.
AU - Verdonk, R.
AU - Van Der Meer, A.
AU - Verhagen, M.
N1 - Publisher Copyright:
© 2023 American Association for the Study of Liver Diseases.
PY - 2024/3
Y1 - 2024/3
N2 - Background and Aims: The International Autoimmune Hepatitis Group retrospective registry (IAIHG-RR) is a web-based platform with subjects enrolled with a clinical diagnosis of autoimmune hepatitis (AIH). As prognostic factor studies with enough power are scarce, this study aimed to ascertain data quality and identify prognostic factors in the IAIHG-RR cohort. Methods: This retrospective, observational, multicenter study included all patients with a clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external validation of completeness and consistency for 29 predefined variables. Cox regression was used to identify risk factors for liver-related death and liver transplantation (LT). Results: This analysis included 2559 patients across 7 countries. In 1700 patients, follow-up was available, with a completeness of individual data of 90% (range: 30-100). During a median follow-up period of 10 (range: 0-49) years, there were 229 deaths, of which 116 were liver-related, and 143 patients underwent LT. Non-White ethnicity (HR 4.1 95% CI: 2.3-7.1), cirrhosis (HR 3.5 95% CI: 2.3-5.5), variant syndrome with primary sclerosing cholangitis (PSC) (HR 3.1 95% CI: 1.6-6.2), and lack of complete biochemical response within 6 months (HR 5.7 95% CI: 3.4-9.6) were independent prognostic factors. Conclusions: The IAIHG-RR represents the world's largest AIH cohort with moderate-to-good data quality and a relevant number of liver-related events. The registry is a suitable platform for patient selection in future studies. Lack of complete biochemical response to treatment, non-White ethnicity, cirrhosis, and PSC-AIH were associated with liver-related death and LT.
AB - Background and Aims: The International Autoimmune Hepatitis Group retrospective registry (IAIHG-RR) is a web-based platform with subjects enrolled with a clinical diagnosis of autoimmune hepatitis (AIH). As prognostic factor studies with enough power are scarce, this study aimed to ascertain data quality and identify prognostic factors in the IAIHG-RR cohort. Methods: This retrospective, observational, multicenter study included all patients with a clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external validation of completeness and consistency for 29 predefined variables. Cox regression was used to identify risk factors for liver-related death and liver transplantation (LT). Results: This analysis included 2559 patients across 7 countries. In 1700 patients, follow-up was available, with a completeness of individual data of 90% (range: 30-100). During a median follow-up period of 10 (range: 0-49) years, there were 229 deaths, of which 116 were liver-related, and 143 patients underwent LT. Non-White ethnicity (HR 4.1 95% CI: 2.3-7.1), cirrhosis (HR 3.5 95% CI: 2.3-5.5), variant syndrome with primary sclerosing cholangitis (PSC) (HR 3.1 95% CI: 1.6-6.2), and lack of complete biochemical response within 6 months (HR 5.7 95% CI: 3.4-9.6) were independent prognostic factors. Conclusions: The IAIHG-RR represents the world's largest AIH cohort with moderate-to-good data quality and a relevant number of liver-related events. The registry is a suitable platform for patient selection in future studies. Lack of complete biochemical response to treatment, non-White ethnicity, cirrhosis, and PSC-AIH were associated with liver-related death and LT.
UR - http://www.scopus.com/inward/record.url?scp=85185343173&partnerID=8YFLogxK
U2 - 10.1097/HEP.0000000000000589
DO - 10.1097/HEP.0000000000000589
M3 - Article
C2 - 37676683
AN - SCOPUS:85185343173
SN - 0270-9139
VL - 79
SP - 538
EP - 550
JO - Hepatology
JF - Hepatology
IS - 3
ER -